Kazuya Ishiwata
Overview
Explore the profile of Kazuya Ishiwata including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
58
Citations
326
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nagayama T, Fujiwara S, Nishiwaki S, Wada F, Uchida N, Tanaka M, et al.
Blood Adv
. 2025 Mar;
PMID: 40085961
Allogeneic hematopoietic stem cell transplantation (HSCT) from HLA-matched donors is the gold standard. However, haploidentical stem cell transplantation using posttransplant cyclophosphamide (PTCY-haplo) and cord blood transplants (CBTs) are alternatives when...
2.
Yamamoto J, Yamaguchi K, Watanabe O, Kageyama K, Taya Y, Kaji D, et al.
Intern Med
. 2025 Feb;
PMID: 39924229
This is the first report of therapy-related mixed-phenotype acute leukemia (MPAL) characterized by B-cell, T-cell, and myeloid lineage phenotypes. A 68-year-old man, who was in complete remission after chemoradiotherapy for...
3.
Takagi S, Watanabe O, Yamaguchi K, Kageyama K, Kaji D, Taya Y, et al.
Bone Marrow Transplant
. 2024 Dec;
60(3):418-421.
PMID: 39715812
No abstract available.
4.
Harada K, Kanda J, Hirayama M, Wada F, Uchida N, Tanaka M, et al.
Transplant Cell Ther
. 2024 Nov;
31(2):103.e1-103.e13.
PMID: 39603416
Unrelated cord blood transplantation (UCBT) and haploidentical transplantation using posttransplant cyclophosphamide (PTCy-haplo) are alternatives for patients lacking a human leukocyte antigen-matched donor. CD34 cell counts in cord blood affect transplantation...
5.
Nishikubo M, Shimomura Y, Nakaya Y, Shinohara A, Uchida N, Takayama N, et al.
Bone Marrow Transplant
. 2024 Sep;
59(12):1735-1743.
PMID: 39322651
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment for relapsed or refractory non-Hodgkin lymphoma (R/R NHL). Allo-HSCT using post-transplant cyclophosphamide (PTCY-haplo) and umbilical cord blood transplantation (uCBT) are...
6.
Osada M, Yamamoto H, Watanabe O, Yamaguchi K, Kageyama K, Kaji D, et al.
Transplant Cell Ther
. 2024 Apr;
30(7):696.e1-696.e14.
PMID: 38641011
Anti-human leukocyte antigen (HLA) antibodies other than those against HLA-A, -B, -C, and DRB1 are a risk factor for engraftment delay and failure, especially in cord blood transplantation (CBT). The...
7.
Yamaguchi K, Yamamoto H, Izutsu K, Yuasa M, Kaji D, Nishida A, et al.
J Infect Chemother
. 2024 Mar;
30(11):1166-1169.
PMID: 38514025
BK virus (BKV) encephalitis is a rare complication after hematopoietic stem cell transplantation (HSCT). A 43-year-old woman with recurrent follicular lymphoma after autologous HSCT received allogeneic bone marrow transplantation from...
8.
Tsumita K, Takagi S, Asano-Mori Y, Watanabe O, Shindo M, Yamaguchi K, et al.
Int J Hematol
. 2024 Feb;
119(5):573-582.
PMID: 38407785
The number of umbilical cord blood transplantation (U-CBT) procedures has been growing annually, but little research has been done on long-term immune recovery after U-CBT. Infection risk is high in...
9.
Kato K, Takagi S, Takano H, Tsunoda S, Watanabe O, Yamaguchi K, et al.
Int J Hematol
. 2024 Jan;
119(2):205-209.
PMID: 38236369
Acquired point mutations in the ABL1 gene are widely recognized as a cause of Philadelphia chromosome-positive B cell precursor acute lymphoblastic leukemia (Ph B-ALL) that is resistant to tyrosine kinase...
10.
Oba Y, Koizumi R, Kageyama K, Yoshimoto M, Kurihara S, Ikuma D, et al.
Cancer Diagn Progn
. 2024 Jan;
4(1):66-70.
PMID: 38173667
Background/aim: Acute lymphoblastic leukemia (ALL) is a blood malignancy characterized by a rapid proliferation of lymphoid progenitor cells. Extramedullary relapse (EMR) is the recurrence of leukemia that occurs outside the...